viewAecon Group

Aecon touches 6-month low after posting Q2 loss on weak mining construction business


Aecon Group Inc. (TSX:ARE), a Canadian construction company, fell to the lowest in about six months after posting a net loss in its second quarter, hurt by lower revenue and margins in its mining construction segment.

Shares were down 1.8 percent at C$16.31 at 1:31 p.m. in Toronto, after reaching C$15.49, the lowest intraday price since Feb. 26.

Net loss was $12.2 million, or $0.23 per share, in the April-to-June period, compared with net income of $7.9 million, or $0.13 per diluted share, the Toronto-based company said in a statement late yesterday.

Adjusted earnings per share were $0.26.

Overall revenue was $589.6 billion, down from $697.6 million.

Revenue from the company's energy segment was up $19.1 million; revenue from Infrastructure was down $48.8 million; and Mining revenue fell $85.2 million.

Analysts had estimated a profit of $0.12 per share with $641.52 million of revenue.

Aecon said its mining sector has been recovering since the quarter ended and Aecon expects the second half of the year to be stronger in 2014 than is usually the case.

It also said that it has been awarded $280 million for three large contracts since the quarter ended on June 30 — one for each of its three operating segments.

"While we were disappointed by the delay we experienced in securing the additional work we have now booked for our mining business and the temporary client production shutdowns in the oil sands during the second quarter, we move forward with confidence into the second half of 2014 with major new Infrastructure projects ramped up and significant mining work in hand," Chief Executive Officer Teri McKibbon said in the statement.




Quick facts: Aecon Group

Price: 14.49 CAD

Market: TSX
Market Cap: $867.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: PetVivo preparing to bring their lead medical device Kush to...

PetVivo (OTCQB: PETV) CEO John Lai joined Steve Darling from Proactive to discuss the company that is developing a treatment for osteoarthritis is horses and dogs. The company’s lead medical device is called Kush and according to PetVivo it mimics cartilage. Lai tells Proactive about the size...

5 hours, 1 minute ago

2 min read